scispace - formally typeset
Search or ask a question
Institution

International Agency for Research on Cancer

GovernmentLyon, France
About: International Agency for Research on Cancer is a government organization based out in Lyon, France. It is known for research contribution in the topics: Cancer & Population. The organization has 2989 authors who have published 9010 publications receiving 929752 citations. The organization is also known as: IARC.


Papers
More filters
Journal ArticleDOI
TL;DR: An increased incidence occurs in the world at tumor sites related to human papilloma virus infection in relation to changes in sexual habits and there is an increase in tendency in countries without prevention and a decrease in countries having an active policy of prevention of alcohol and tobacco consumption.
Abstract: The classification of sites in tumors of the oral cavity, oropharynx, pharynx, and hypopharynx varies in the literature. More than 90% of these tumors of the mucosal lining are classified as squamous cell carcinoma developed from premalignant lesions such as leukoplakia and erythroleukoplakia. These carcinomas are associated to environmental and lifestyle risk factors, among which tobacco and alcohol play a major role. In addition to tobacco smoking, tobacco chewing is another risk factor as well as chewing betel quid and areca nut in Asia. Certain strains of virus, such as the sexually transmitted human papilloma virus, also play a carcinogenetic role. The temporal trends in incidence of these tumors relate to environmental factors; there is an increase in tendency in countries without prevention and a decrease in countries having an active policy of prevention of alcohol and tobacco consumption. In contrast, an increased incidence occurs in the world at tumor sites related to human papilloma virus infection in relation to changes in sexual habits.

233 citations

Journal ArticleDOI
01 May 1970-Cancer
TL;DR: The alpha‐fetoprotein test has proven to be highly specific for primary liver cell cancer and may be used with advantage in differential diagnosis of this disease and in epidemiologic studies.
Abstract: Sera from 813 patients were examined independently by 3 test centers for the presence of alpha-fetoprotein (AFP). The sera were collected at 5 different African centers and 2 non-African centers. There was disagreement in the serologic results among the 3 test laboratories in only 27, or 3.3%, of cases. A clinical and/or histologic diagnosis of primary liver cancer had been made in 231 of the cases in which there was serologic agreement, and 151, or 65.4%, of these were positive for AFP. If only those cases with histologic confirmation of liver cell cancer were included, the percentage of cases with AFP increases to 75%. Analysis of the results from each collection center has been made, and the basis for “false-positives” and serologic disagreements is discussed. The test has proven to be highly specific for primary liver cell cancer and may be used with advantage in differential diagnosis of this disease and in epidemiologic studies.

233 citations

Journal ArticleDOI
Ming-Huei Chen, Laura M. Raffield1, Abdou Mousas2, Saori Sakaue3, Jennifer E. Huffman4, Arden Moscati5, Bhavi Trivedi6, Tao Jiang7, Parsa Akbari8, Dragana Vuckovic9, Erik L. Bao10, Xue Zhong11, Regina Manansala12, Véronique Laplante13, Minhui Chen14, Ken Sin Lo2, Huijun Qian1, Caleb A. Lareau10, Mélissa Beaudoin2, Karen A. Hunt6, Masato Akiyama15, Traci M. Bartz16, Yoav Ben-Shlomo17, Andrew D Beswick17, Jette Bork-Jensen18, Erwin P. Bottinger5, Jennifer A. Brody16, Frank J. A. van Rooij19, Kumaraswamynaidu Chitrala20, Kelly Cho21, Hélène Choquet22, Adolfo Correa23, John Danesh, Emanuele Di Angelantonio8, Niki Dimou24, Jingzhong Ding25, Paul Elliott26, Tõnu Esko27, Michele K. Evans20, James S. Floyd16, Linda Broer19, Niels Grarup18, Michael H. Guo28, Andreas Greinacher29, Jeffrey Haessler30, Torben Hansen18, Joanna M. M. Howson7, Qin Qin Huang9, Wei Huang31, Eric Jorgenson22, Tim Kacprowski32, Mika Kähönen33, Yoichiro Kamatani34, Masahiro Kanai10, Savita Karthikeyan7, Fotis Koskeridis35, Leslie A. Lange36, Terho Lehtimäki, Markus M. Lerch29, Allan Linneberg18, Yongmei Liu37, Leo-Pekka Lyytikäinen, Ani Manichaikul38, Hilary C. Martin9, Koichi Matsuda34, Karen L. Mohlke1, Nina Mononen, Yoshinori Murakami34, Girish N. Nadkarni5, Matthias Nauck29, Kjell Nikus33, Willem H. Ouwehand39, Nathan Pankratz40, Oluf Pedersen18, Michael Preuss5, Bruce M. Psaty16, Olli T. Raitakari41, David J. Roberts8, Stephen S. Rich38, Benjamin Rodriguez, Jonathan D. Rosen1, Jerome I. Rotter42, Petra Schubert4, Cassandra N. Spracklen1, Praveen Surendran7, Hua Tang43, Jean-Claude Tardif2, Richard C. Trembath44, Mohsen Ghanbari45, Uwe Völker29, Henry Völzke29, Nicholas A. Watkins39, Alan B. Zonderman20, VA Million Veteran Program46, Peter W.F. Wilson46, Yun Li1, Adam S. Butterworth8, Jean-François Gauchat13, Charleston W. K. Chiang14, Bingshan Li11, Ruth J. F. Loos5, William J. Astle8, Evangelos Evangelou26, David A. van Heel6, Vijay G. Sankaran10, Yukinori Okada3, Nicole Soranzo9, Andrew D. Johnson, Alexander P. Reiner16, Paul L. Auer12, Guillaume Lettre13, Guillaume Lettre2 
03 Sep 2020-Cell
TL;DR: The clinical significance and predictive value of trans-ethnic variants in multiple populations are explored, genetic architecture and the effect of natural selection on these blood phenotypes between populations are compared and the value of a more global representation of populations in genetic studies is highlighted.

233 citations

Journal ArticleDOI
TL;DR: The decreasing BTC mortality trends essentially reflect more widespread and earlier adoption of cholecystectomy in several countries, since gallstones are the major risk factor for BTC.

232 citations

Journal ArticleDOI
TL;DR: Oral cancer is a disease of the poor and dispossessed, and reducing social inequalities requires national policies co-ordinated with wider health and social initiatives – the common risk factor approach.
Abstract: The mouth and oropharynx are among the ten most common sites affected by cancer worldwide, but global incidence varies widely. Five-year survival rates exceed 50% in only the best treatment centers. Causes are predominantly lifestyle-related: Tobacco, areca nut, alcohol, poor diet, viral infections, and pollution are all important etiological factors. Oral cancer is a disease of the poor and dispossessed, and reducing social inequalities requires national policies co-ordinated with wider health and social initiatives - the common risk factor approach: control of the environment; safe water; adequate food; public and professional education about early signs and symptoms; early diagnosis and intervention; evidence-based treatments appropriate to available resources; and thoughtful rehabilitation and palliative care. Reductions in inequalities, both within and between countries, are more likely to accrue from the application of existing knowledge in a whole-of-society approach. Basic research aimed at determining individual predisposition and acquired genetic determinants of carcinogenesis and tumor progression, thus allowing for targeted therapies, should be pursued opportunistically.

231 citations


Authors

Showing all 3012 results

NameH-indexPapersCitations
David J. Hunter2131836207050
Kay-Tee Khaw1741389138782
Elio Riboli1581136110499
Silvia Franceschi1551340112504
Stephen J. Chanock1541220119390
Paolo Boffetta148145593876
Timothy J. Key14680890810
Hans-Olov Adami14590883473
Joseph J.Y. Sung142124092035
Heiner Boeing140102492580
Anne Tjønneland139134591556
Kim Overvad139119686018
Sheila Bingham13651967332
Pasi A. Jänne13668589488
Peter Kraft13582182116
Network Information
Related Institutions (5)
German Cancer Research Center
26.3K papers, 1.4M citations

92% related

Fred Hutchinson Cancer Research Center
30.9K papers, 2.2M citations

89% related

University of Texas MD Anderson Cancer Center
92.5K papers, 4.7M citations

89% related

National Institutes of Health
297.8K papers, 21.3M citations

88% related

Memorial Sloan Kettering Cancer Center
65.3K papers, 4.4M citations

88% related

Performance
Metrics
No. of papers from the Institution in previous years
YearPapers
20238
202233
2021483
2020495
2019423
2018400